Orlando Galego1, Ana Gouveia2, Sónia Batista2, Cristina Moura3, Egídio Machado3. 1. Coimbra Hospital and University Centre, Department of Neuroradiology, Coimbra, Portugal orlando.galego@gmail.com. 2. Coimbra Hospital and University Centre, Department of Neurology, Coimbra, Portugal. 3. Coimbra Hospital and University Centre, Department of Neuroradiology, Coimbra, Portugal.
Abstract
UNLABELLED: Grey matter atrophy has been shown in primary progressive multiple sclerosis (PPMS), but its association with physical incapacity is unclear. We submitted 19 patients with PPMS to a neurological evaluation and brain magnetic resonance imaging (MRI) with volumetric analysis using FreeSurfer. We found no relation between the Expanded Disability Status Scale or disease duration and the grey matter or white matter structures analysed. Lesion load was negatively correlated with cortical and subcortical grey matter volumes, but not with total white matter volume. We concluded that physical disability in PPMS is not directly related to brain atrophy and that focal inflammatory white matter lesions may contribute to progressive neuronal degeneration. INTRODUCTION: Primary progressive multiple sclerosis (PPMS) is characterized by chronic progression since onset, with predominant involvement of the spinal cord and prominent neurodegeneration. Grey matter atrophy has been shown in patients with PPMS, but its association with clinical incapacity is uncertain. We investigated the relationship between regional brain atrophy and physical disability in patients with PPMS. METHODS: Patients with an established diagnosis of PPMS underwent a neurological evaluation followed by brain MRI at 1.5 T. Volumetric analysis was performed with FreeSurfer software, and evaluated the neocortex, total white matter, total subcortical grey matter, putamen, caudate, globus pallidus, thalamus, hippocampus, brainstem, corpus callosum and pre-central gyrus volumes. Clinical data obtained included physical disability as measured by the Expanded Disability Status Scale (EDSS). RESULTS: Nineteen patients were included, 14 female (73.7%), mean age of 55.7 (SD 7.6) and mean disease duration of 13.0 years (SD 8.8). Median EDSS score was 6.0 (3.5-8.0). The average T1 lesion load (4.9 cm³, SD 3.4) and T2 load (10.5 cm³, SD 9.9) did not relate to disease duration. There was no significant correlation between EDSS score or disease duration and the cortical grey matter, deep grey matter or white matter structures analysed. Lesion load was negatively correlated with cortical and subcortical grey matter volumes (p < 0.05), but not with total white matter volume. CONCLUSIONS: Physical disability in PPMS is not directly related to brain volume loss. Grey matter atrophy correlates with lesion load in patients with PPMS, indicating that focal inflammatory white matter lesions may contribute to progressive neuronal degeneration.
UNLABELLED: Grey matter atrophy has been shown in primary progressive multiple sclerosis (PPMS), but its association with physical incapacity is unclear. We submitted 19 patients with PPMS to a neurological evaluation and brain magnetic resonance imaging (MRI) with volumetric analysis using FreeSurfer. We found no relation between the Expanded Disability Status Scale or disease duration and the grey matter or white matter structures analysed. Lesion load was negatively correlated with cortical and subcortical grey matter volumes, but not with total white matter volume. We concluded that physical disability in PPMS is not directly related to brain atrophy and that focal inflammatory white matter lesions may contribute to progressive neuronal degeneration. INTRODUCTION: Primary progressive multiple sclerosis (PPMS) is characterized by chronic progression since onset, with predominant involvement of the spinal cord and prominent neurodegeneration. Grey matter atrophy has been shown in patients with PPMS, but its association with clinical incapacity is uncertain. We investigated the relationship between regional brain atrophy and physical disability in patients with PPMS. METHODS:Patients with an established diagnosis of PPMS underwent a neurological evaluation followed by brain MRI at 1.5 T. Volumetric analysis was performed with FreeSurfer software, and evaluated the neocortex, total white matter, total subcortical grey matter, putamen, caudate, globus pallidus, thalamus, hippocampus, brainstem, corpus callosum and pre-central gyrus volumes. Clinical data obtained included physical disability as measured by the Expanded Disability Status Scale (EDSS). RESULTS: Nineteen patients were included, 14 female (73.7%), mean age of 55.7 (SD 7.6) and mean disease duration of 13.0 years (SD 8.8). Median EDSS score was 6.0 (3.5-8.0). The average T1 lesion load (4.9 cm³, SD 3.4) and T2 load (10.5 cm³, SD 9.9) did not relate to disease duration. There was no significant correlation between EDSS score or disease duration and the cortical grey matter, deep grey matter or white matter structures analysed. Lesion load was negatively correlated with cortical and subcortical grey matter volumes (p < 0.05), but not with total white matter volume. CONCLUSIONS: Physical disability in PPMS is not directly related to brain volume loss. Grey matter atrophy correlates with lesion load in patients with PPMS, indicating that focal inflammatory white matter lesions may contribute to progressive neuronal degeneration.
Authors: Marco Battaglini; Antonio Giorgio; Maria L Stromillo; Maria L Bartolozzi; Leonello Guidi; Antonio Federico; Nicola De Stefano Journal: J Neurol Sci Date: 2009-03-16 Impact factor: 3.181
Authors: Benedetta Bodini; Zhaleh Khaleeli; Mara Cercignani; David H Miller; Alan J Thompson; Olga Ciccarelli Journal: Hum Brain Mapp Date: 2009-09 Impact factor: 5.038
Authors: Raju Kapoor; Julian Furby; Thomas Hayton; Kenneth J Smith; Daniel R Altmann; Robert Brenner; Jeremy Chataway; Richard A C Hughes; David H Miller Journal: Lancet Neurol Date: 2010-06-08 Impact factor: 44.182
Authors: M P Amato; E Portaccio; M L Stromillo; B Goretti; V Zipoli; G Siracusa; M Battaglini; A Giorgio; M L Bartolozzi; L Guidi; S Sorbi; A Federico; N De Stefano Journal: Neurology Date: 2008-08-26 Impact factor: 9.910
Authors: Chris H Polman; Stephen C Reingold; Brenda Banwell; Michel Clanet; Jeffrey A Cohen; Massimo Filippi; Kazuo Fujihara; Eva Havrdova; Michael Hutchinson; Ludwig Kappos; Fred D Lublin; Xavier Montalban; Paul O'Connor; Magnhild Sandberg-Wollheim; Alan J Thompson; Emmanuelle Waubant; Brian Weinshenker; Jerry S Wolinsky Journal: Ann Neurol Date: 2011-02 Impact factor: 10.422
Authors: V M Anderson; C A M Wheeler-Kingshott; K Abdel-Aziz; D H Miller; A Toosy; A J Thompson; O Ciccarelli Journal: Mult Scler Date: 2011-04-20 Impact factor: 6.312
Authors: C Thaler; T D Faizy; J Sedlacik; B Holst; K Stürner; C Heesen; J-P Stellmann; J Fiehler; S Siemonsen Journal: AJNR Am J Neuroradiol Date: 2016-11-10 Impact factor: 3.825
Authors: A Burgetova; P Dusek; M Vaneckova; D Horakova; C Langkammer; J Krasensky; L Sobisek; P Matras; M Masek; Z Seidl Journal: AJNR Am J Neuroradiol Date: 2017-04-27 Impact factor: 3.825